Vildagliptin: A new DPP-4 Inhibitor for the Treatment of Type 2 Diabetes  

Oleh:

Ronald CW Ma ; Chun, Chung Chow

Jenis: Article from Bulletin/Magazine - ilmiah internasional
Dalam koleksi: Medical Progress vol. 36 no. 09 (Sep. 2009), page 446.
Topik: DRUG THERAPY; Incretin Pathway; sitagliptin

Ketersediaan

Perpustakaan FK Nomor Panggil: M36.K.2009.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Vildagliptin is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). In this review, the authors discuss the characteristics and clinical experience with vildagliptin.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali